FIELD: biotechnology.
SUBSTANCE: method is proposed for determining the activity of the classical and alternative complement pathways in the blood serum of mice, including the lysis reaction of 0.25% suspension of rabbit erythrocytes sensitized with human antibodies (EcrAT), 12.5% mouse serum at 37.0±0.5°C, construction of a calibration graph of the dependence of the optical density of A620 suspension on the lysis of rabbit erythrocytes, which determines the degree of EcrAT lysis. The total complement activity is determined under VBS2+ conditions and incubated for 10 min, the activity of the alternative complement pathway is determined at the same ratios in the hemolytic system only under VBS-Mg2+ -EGT conditions and 30 min incubation; mouse classic complement pathway activity is defined as the difference between total complement activity and that of the alternative complement pathway.
EFFECT: invention provides an extension of the arsenal of methods for studying complement-mediated erythrocyte lysis over time.
1 cl, 7 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
SCREENING TEST FOR DETERMINATION OF THE FUNCTIONAL ACTIVITY OF THE RAT COMPLEMENT SYSTEM | 2022 |
|
RU2786208C1 |
METHOD OF PREDICTING SEVERITY OF SYSTEMIC INFLAMMATORY RESPONSE IN HUMAN BODY IN DISEASES | 2022 |
|
RU2808416C1 |
METHOD FOR DETERMINING THE INHIBITORY POTENTIAL OF BLOOD FOR PREDICTING UNCONTROLLED ACTIVATION OF COMPLEMENT SYSTEM IN COVID-19 | 2023 |
|
RU2814496C1 |
METHOD FOR DETERMINING COMPLEMENT-ACTIVATING FUNCTION OF SARS-CoV-2 ANTIBODIES FOR PREDICTING SEVERITY OF COVID-19 | 2023 |
|
RU2818351C1 |
SCREENING TEST FOR DETERMINING THE FUNCTIONAL ACTIVITY OF THE CLASSIC COMPLEMENT PATHWAY | 2018 |
|
RU2704121C1 |
METHOD OF DETERMINING C3-CONVERTASE STABILISATION OF CLASSICAL WAY OF HUMAN COMPLEMENT ACTIVATION | 2013 |
|
RU2549468C2 |
METHOD FOR DETERMINING THE FUNCTIONAL ACTIVITY OF THE HUMAN COMPLEMENT SYSTEM FOR PREDICTING THE SEVERITY OF THE COURSE OF A SYSTEMIC INFLAMMATORY REACTION | 2021 |
|
RU2756764C1 |
METHOD FOR DETERMINING FUNCTIONAL ACTIVITY OF IONISED CALCIUM IN HUMAN BLOOD SERUM | 2013 |
|
RU2526824C1 |
METHOD FOR DETERMINING LYSIS MULTIPLE MODIFIED LOW DENSITY LIPOPROTEIN | 2015 |
|
RU2577719C1 |
METHOD FOR RAPID ANALYSIS OF CHOLESTEROL IN IMMUNE COMPLEXES | 2013 |
|
RU2538685C1 |
Authors
Dates
2023-07-20—Published
2022-11-17—Filed